PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.95
0.00 (0.00%)
Aug 21, 2026, 5:31 PM CET
PolyPeptide Group AG Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, PolyPeptide Group AG stock has a consensus rating of "Hold" and an average price target of CHF 39.38. The average 1-year stock price forecast is 10.40% lower than the current stock price, while the lowest is CHF 25.89 (-41.09%) and the highest is CHF 44.08 (+0.30%).
Price Target: CHF 39.38 (-10.40%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for PolyPeptide Group AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg Bank | Berenberg Bank | Hold Downgrades CHF 38.00 → CHF 44.00 | Hold | Downgrades | CHF 38.00 → CHF 44.00 | +0.11% | Aug 18, 2026 |
| Barclays | Barclays | Hold Downgrades CHF 40.00 → CHF 44.31 | Hold | Downgrades | CHF 40.00 → CHF 44.31 | +0.82% | Aug 14, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades CHF 44.00 | Hold | Downgrades | CHF 44.00 | +0.11% | Jul 7, 2026 |
| UBS | UBS | Buy Maintains CHF 40.00 | Buy | Maintains | CHF 40.00 | -8.99% | May 7, 2026 |
Financial Forecast
Revenue This Year
497.55M
from 389.33M
Increased by 27.80%
Revenue Next Year
573.65M
from 497.55M
Increased by 15.29%
EPS This Year
0.88
from -0.64
EPS Next Year
1.54
from 0.88
Increased by 76.29%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.